Tonix Pharmaceuticals Holding (TNXP) Change in Account Payables (2010 - 2026)

Tonix Pharmaceuticals Holding's Change in Account Payables history runs 17 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Change in Account Payables rose 534.28% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $4.9 million, a 303.16% increase from a year earlier, with the FY2025 full-year figure at $3.0 million, up 222.98% from the prior year.
• Change in Account Payables improved to $1.5 million in Q1 2026 per TNXP's latest filing, from -$738000.0 in the prior quarter.
• Across five years, Change in Account Payables topped out at $3.7 million in Q2 2024 and bottomed at -$6.4 million in Q3 2024.
• The 5-year median for Change in Account Payables is $581000.0 (2024), against an average of $54058.8.
• Across the five-year window, Change in Account Payables jumped 1844.87% in 2022 and tumbled 725.07% in 2024, its largest moves.
• Year by year, Change in Account Payables stood at $3.0 million in 2022, then tumbled by 229.73% to -$3.9 million in 2023, then jumped by 114.76% to $581000.0 in 2024, then plunged by 227.02% to -$738000.0 in 2025, then soared by 307.72% to $1.5 million in 2026.
• Per Business Quant, the three latest TNXP Change in Account Payables figures stand at $1.5 million (Q1 2026), -$738000.0 (Q4 2025), and $1.0 million (Q3 2025).